Found: 21
Select item for more details and to access through your institution.
Molecular pathogenesis of multiple myeloma: basic and clinical updates.
- Published in:
- International Journal of Hematology, 2013, v. 97, n. 3, p. 313, doi. 10.1007/s12185-013-1291-2
- By:
- Publication type:
- Article
Identification of kinetin riboside as a repressor of CCND1 and CCND2 with preclinical antimyeloma activity.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26598-w
- By:
- Publication type:
- Article
Transcriptional repression by the HDAC4-RelB-p52 complex regulates multiple myeloma survival and growth.
- Published in:
- Scientific Reports, 2015, p. 8428, doi. 10.1038/ncomms9428
- By:
- Publication type:
- Article
Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-07305-8
- By:
- Publication type:
- Article
High-Resolution Genomic Analysis in Waldenström's Macroglobulinemia Identifies Disease-Specific and Common Abnormalities with Marginal Zone Lymphomas.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 1, p. 39
- By:
- Publication type:
- Article
Che-1-induced inhibition of mTOR pathway enables stress-induced autophagy.
- Published in:
- EMBO Journal, 2015, v. 34, n. 9, p. 1214, doi. 10.15252/embj.201489920
- By:
- Publication type:
- Article
MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites.
- Published in:
- Nature, 2011, v. 470, n. 7332, p. 124, doi. 10.1038/nature09658
- By:
- Publication type:
- Article
Bone marrow transplantation generates T cell-dependent control of myeloma in mice.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Immunosurveillance and therapy of multiple myeloma are CD226 dependent.
- Published in:
- 2015
- By:
- Publication type:
- journal article
TIM-3<sup>+</sup> CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies.
- Published in:
- Science Immunology, 2024, v. 9, n. 94, p. 1, doi. 10.1126/sciimmunol.adg1094
- By:
- Publication type:
- Article
Transcriptional repression by the HDAC4-RelB-p52 complex regulates multiple myeloma survival and growth.
- Published in:
- Nature Communications, 2015, v. 6, n. 10, p. 8428, doi. 10.1038/ncomms9428
- By:
- Publication type:
- Article
P-099: Perturbation of CDK7 and super-enhancer driven transcriptional programs synergistically halts multiple myeloma cell proliferation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S93, doi. 10.1016/S2152-2650(21)02233-3
- By:
- Publication type:
- Article
Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00851-5
- By:
- Publication type:
- Article
Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00851-5
- By:
- Publication type:
- Article
V. Molecular classification and risk stratification of myeloma.
- Published in:
- Hematological Oncology, 2013, v. 31, p. 38, doi. 10.1002/hon.2065
- By:
- Publication type:
- Article
Osteopontin dysregulation and lytic bone lesions in multiple myeloma.
- Published in:
- Hematological Oncology, 2007, v. 25, n. 1, p. 16, doi. 10.1002/hon.803
- By:
- Publication type:
- Article
Phase II trial of nab-paclitaxel in patients with relapsed or refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 12, p. E504, doi. 10.1002/ajh.24548
- By:
- Publication type:
- Article
Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair.
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0495-y
- By:
- Publication type:
- Article
Role of Pirh2 in Mediating the Regulation of p53 and c-Myc.
- Published in:
- PLoS Genetics, 2011, v. 7, n. 11, p. 1, doi. 10.1371/journal.pgen.1002360
- By:
- Publication type:
- Article
Single-Cell Proteomics and Tumor RNAseq Identify Novel Pathways Associated With Clofazimine Sensitivity in PI- and IMiD- Resistant Myeloma, and Putative Stem-Like Cells.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.842200
- By:
- Publication type:
- Article